Squarepoint
RMD icon

Squarepoint’s ResMed RMD Stock Holding History

Squarepoint’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.64M Sell
7,300
-6,300
-46% -$1.57M ﹤0.01% 2356
2025
Q4 		$3.28M Buy
+13,600
New +$3.48M ﹤0.01% 1730
2025
Q3 		– Sell
-1,600
Closed -$413K – 4896
2025
Q2 		$413K Buy
+1,600
New +$382K ﹤0.01% 3431
2024
Q4 		– Sell
-2,900
Closed -$708K – 5423
2024
Q3 		$708K Buy
2,900
+900
+45% +$201K ﹤0.01% 2860
2024
Q2 		$383K Buy
+2,000
New +$406K ﹤0.01% 3270
2024
Q1 		– Sell
-6,100
Closed -$1.05M – 4521
2023
Q4 		$1.05M Sell
6,100
-4,600
-43% -$707K ﹤0.01% 2487
2023
Q3 		$1.58M Buy
+10,700
New +$1.93M ﹤0.01% 1999

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint's RMD Position: Q1 2026 in Review

Squarepoint reduced its ResMed (RMD) stake by 97% in Q1 2026, selling an estimated $27.5M and leaving 3,872 shares worth $869K. The position accounts for ﹤0.01% of the portfolio, ranked #2902.

Squarepoint first reported a position in RMD in Q4 2015 and has held it in 30 quarters since. The position peaked at $141M in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Squarepoint held 3,872 shares of ResMed worth $869K as of Q1 2026.
  • Squarepoint sold 110,285 ResMed shares in Q1 2026, an estimated $27.5M.
  • ResMed made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2902 holding.
  • Squarepoint first reported a position in ResMed in Q4 2015 and has held it in 30 quarters since.
  • Squarepoint's ResMed position peaked at $141M in Q2 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.